Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Name: Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
SKU: 2766
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: eduard-parellada, ethnicityrace, health-disparities, illness-characteristics, ipolar-disorder, md, msc, phd

Description

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Thomas J. Raedler, MD: Lithium-Induced Nephropathies

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Related products

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Thomas J. Raedler, MD: Lithium-Induced Nephropathies